Toward gender equity in contraception: male contraceptive passes safety trial.

eBioMedicine
EBioMedicine · 2025 · doi:10.1016/j.ebiom.2025.105938 · PMID:40940106 · PMC12789702
OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-06 ⓘ

A male contraceptive passed a safety trial, advancing research toward gender equity in contraception options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-20T09:27:46.357103+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0